Colitis is a major gastrointestinal disease that threatens human health. In this study, a synbiotic composed of inulin and
Pediococcus acidilactici
(
P. acidilactici
) was investigated for its ability to alleviate dextran sulfate sodium (DSS)-induced colitis. The results revealed that the synbiotic, composed of inulin and
P. acidilactici
, attenuated the body weight loss and disease activity index (DAI) score in mice with DSS-mediated colitis. Determination of biochemical indicators found that the synbiotic increased anti-oxidation and alleviated inflammation in mice. Additionally, histopathological examination revealed that colonic goblet cell loss and severe mucosal damage in the model group were significantly reversed by the combination of inulin and
P. acidilactici
. Moreover, synbiotic treatment significantly reduced the levels of IL-1β, TNF-α, and IL-6 in the serum of mice. Thus, a synbiotic composed of inulin and
P. acidilactici
has preventive and therapeutic effects on DSSinduced colitis in mice.